Skip to main content
L

Lotus Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 1795 TW Manufacturing
Open in API
Filings indexed 2,670 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country TW Taiwan
Listing TW 1795

About Lotus Pharmaceutical Co., Ltd.

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
本公司受邀參加摩根士丹利舉辦之線上法人座談會
Regulatory Filings
2026-04-30 Chinese
115年05月法人說明會簡報
Regulatory Filings
2026-04-30 Chinese
公告本公司115年第一季合併財務報告董事會召開日期為 115年05月11日
Regulatory Filings
2026-04-30 Chinese
公告本公司董事會決議召開115年股東常會 (變更開會地點及新增議案)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a public notice from the issuer’s board of directors announcing the convocation of its 115th Annual General Meeting, including date, venue, agenda items, proposals for shareholder approval and voting procedures. This corresponds to materials sent to shareholders to provide information and solicit votes in advance of the meeting, matching the definition of a Proxy Solicitation & Information Statement.
2026-04-16 Chinese
115年3月背書保證與資金貸與
Regulatory Filings Classification · 1% confidence The document is only 25 characters long, containing a generic placeholder message (‘no data found’) from a public information site and not providing any substantive report or announcement. It does not match any specific form or filing type, so it falls under the fallback category for miscellaneous regulatory filings.
2026-04-10 Chinese
115年3月營業收入
Regulatory Filings Classification · 1% confidence The document is a monthly revenue summary (“查詢彙總報表”) filed on Taiwan’s Market Observation Post System (MOPS). It contains actual monthly and year‐to‐date operating revenue figures with explanations, not merely an announcement of a report. It is not an annual or interim (quarterly) report, earnings release, or any other specific category, so it falls under the general “Regulatory Filings” fallback.
2026-04-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.